Nearly 40% of American hospitals operate with negative margins, and while efforts to optimize revenue have accelerated in recent years, cost containment continues to lag. Healthcare organizations have ...

The global sales of eye infections treatment is estimated to be worth USD 8,125.2 million in 2025 and anticipated to reach a value of USD 11,890.2 million by 2035. Sales are projected to rise at a ...

ISELIN, N.J., June 10, 2025(Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the Scottish Medi ...

Receiving the SMC recommendation of LYTENAVA™ (bevacizumab gamma) for patients with wet AMD is a significant milestone for our company and a testament to our commitment to improving patient outcomes,” ...

According to the latest research by Credence Research, the global Nontuberculous Mycobacterial (NTM) Diagnostic Market was valued at USD 1,814.8 million in 2023 and is projected to reach USD 3,261.1 ...

Guidehealth has developed a platform that connects health systems with AI tools to help providers engage in risk-based ...